Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like 7 PDUFA Dates to Mark on Your Calendars for September September 5, 2017 Denali Therapeutics Adds $155 Million from Takeda March 18, 2018 New Jersey's Leading Pharma, LLC Scores $40M January 7, 2018
